Skip to content

Neuroscience and the Near-Death Experience: Roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins

Karl Jansen

Medical Hypotheses 1990 DOI: 10.1016/0306-9877(90)90048-j (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics Ketamine Near-death experience
Keywords Phencyclidine Nmda receptor Sigma receptor Hallucinogen Dissociative Pharmacology
Citations 96
Key points Proposes that endogenous ligands endopsychosins may be released to protect neurons from ischemic damage, and the near-death experience is a side effect on consciousness with important psychological functions.

Abstract

The Near-Death Experience (NDE) is a dissociative mental state with characteristic features. These can be reproduced by ketamine which acts at sigma sites and blocks N-methyl-D-aspartate (NMDA) linked phencyclidine (PCP) receptors to reduce ischaemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors which suggests an explanation for some NDE's: the endopsychosins may be released in abnormal quantity to protect neurons from ischaemic and other excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.

Comparable studies

Other theoretical and historical papers on near-death experience, most cited first.

Study Year Design Participants
Otherworld Journeys: Accounts of Near-Death Experience in Medieval and Modern Times 1987 Historical analysis
Implications of near-death experiences for a postmaterialist psychology. 2010 Theoretical or philosophical paper
Near-Death Experience as a Probe to Explore (Disconnected) Consciousness 2020 Theoretical or philosophical paper
Near-death experiences between science and prejudice 2012 Theoretical or philosophical paper
Religion, Spirituality and the Near-Death Experience 2003 Theoretical or philosophical paper

Citations in the library

Explore topics